Synthesis of some Heterocyclic compounds bearing Coumarin nucleus and their Anti-inflammatory activity by T. A. Dawoud1, Nadia et al.
I S S N  2 3 2 1 - 8 0 7 X 
V o l u m e  1 2  N u m b e r 5 
J o u r n a l  o f  A d v a n c e s  C h e m i s t r y 
 
 l                                                                                        nuoC rof onnIevitav hcraeseR4442 | Page 
May 2016                                                                                                                                          www.cirworl d.com 
Synthesis of some Heterocyclic compounds bearing Coumarin nucleus 
and their Anti-inflammatory activity 
Nadia T. A. Dawoud1*, Nahed.F.Abdel-Ghaffar2, Mona M Abdl-galil3, Fekria M. A. Soliman4, 
Heba M Zaki5 
1-5
 Department of Chemistry, Faculty of Science (Girls), Al-Azhar University, Nasr City, Cairo, Egypt 
*Corresponding author: E-mail:dawoudnadia@yahoo.com 
ABSTRACT 
Starting from 6-amino-4-methyl-2H-chromen-2-one 1, a series of some new heterocyclic compounds (2-14) incorporating 
coumarin moiety was synthesized and assessed for their anti-inflammatory activity using the carrageenan-induced hind 
paw edema method. The tested coumarin derivatives reduce the edema volume and serum levels of the pro inflammatory 
cytokines, IL-6 and TNF-α, and have effects on promoting production of anti-inflammatory cytokine, IL-10. 
KEYWORDS: 6-amino-4-methylcoumarin, Multi-component reactions, Microwave irradiation assistant, Anti-
inflammatory Activity. 
INTRODUCTION 
The synthesis of coumarins and their derivatives has attracted considerable attention from organic and medicinal chemists 
for many years as a large number of natural and synthetic products contain this heterocyclic nucleus [1–5]. A number of 
natural and synthetic coumarin derivatives have been reported to exert notable antimicrobial [1,2], antifungal [3,4] and 
cytotoxic [5] activity. Furthermore it has been reported by different scientists that coumarin derivatives incorporating, 
pyrazole, thiazole, oxazole pyridine, pyrimidine and 1,3-oxazepine derivatives have also attracted increasing attention due 
to their numerous pharmacological applications and biological activities, such as anti-inflammatory, analgesic, 
antimicrobial, anti-HIV, anti-hypertensive and herbicidal activity [6–10]. MCRs comply with the principles of green 
chemistry in terms of economy of steps as well as many of the stringent criteria of an ideal organic synthesis. In view of 
these observations and in continuation of our previous work on the synthesis of heterocyclic systems and biological 
evaluation [11, 12], we report herein a facile route to various heterocyclic derivatives incorporating coumarin moiety 
.Additionally, we have found that synthesized compounds have shown anti-inflammatory activity. 
EXPERIMENT 
All melting points are not corrected. The infrared spectra on KBr disks were carried on a Pye Unicam SP
3
- 200 
spectrophotometer. The NMR Spectra were measured on a varian EM 60 and JE OL – 90 MHz Spectrometers with TMS 
as internal reference, chemical shifts were expressed in δ ppm. The mass spectra were determined on a FINNI – Gas 
3300 mass spectrometer by direct inlet (Source temperature 90 – 300 ºC, beam energy 70(ev). 
GENERAL PROCEDURE  
Synthesis of 6-amino-4-methyl-2H-chromen-2-one 1  
 A mixture of 4-amino phenol (0.01 mole; 1.09 gm), (0.01 mol) of ethylacetoacetate in concentrated H2SO4 (25 ml) was 
heated with stirring on water bath for half an hour. The reaction product was poured onto ice/cold water; the solid that 
separated was recrystallized from ethanol to give 6-amino-4-methyl-2H-chromen-2-one 1. 
1 as gray crystals, in 70% yield , m. p 252 ºC; anal calc for C10H9NO2(175): C, 68.57;H,5.14 ;N,8.00 ;O,18.29: Found; 
C,68.55;H,5.13;N,7.98;O,18.26. IR (cm
-1
):  3345.50-3295.77(NH2), 1743.76cm
-1
 (CO, Lactone) and 1366.71cm
-1
 (CH3).  
δH: 4.930 (2H,s,NH2) , 6.844 (1H,s,C=CH , Coumarin),7.230 – 7.155 (3H, m, Ar-H) , 1.264 (3H, s, CH3) .
13
C-NMR 
spectrum (400 MHz, DMSO-d6, δ, ppm): 153.006 (C=O), 125.743(C=C), 117.724(C-CH3), 121.86 (CH-C=O), 125.781(C-
H), 131.386(C-N).  
Synthesis of 4-methyl-6-{[(Z)-(3-aryl derivatives)methylidene]amino}-2H-chromen-2-
one  2a-d  
 To ethanolic solution of 1 (0.01 mole; 1.75 gm) ,different  aromatic aldehydes namely, cinnamaldehyde,    3-
nitrobenzaldehyde, 4-methoxybenzaldehyde (0.01 mole) , terphthalaldehyde (0.02 mole) were added in the presence of 
catalytic amount of glacial acetic acid,. The reaction mixture was heated under reflux for 6 hrs. The produced precipitate 
was filtered off on hot, collected, and recrystallised from ethanol to give 2a-d.  
2a Orange powder, 80% yield, m.p.165
o
C; Anal. Calcd for C19H15NO2(289): C,78.89;H,5.19 ;N,4.84 : Found; 
C,78.86;H,5.17;N,4.82 . IR (cm
-1
):1750.0 (C=O, Lactone) , 1604.00 (C=N) ,1448.70( CH3). MS (m/z,%),289 (0.45%) . 
δH:1.239(3H, s, CH3), 6.891(1H, s, CH-Coumarin), 7.82-7.71(8H, m, Ar-H), 7.99(1H, s, CH=N-) and 7.24 – 7.00 (2H, d, 
CH=CH-ethylenic). 
2b Brown powder in 70% yield, m.p.172
o
C; anal calc for C17H12N2O4 (308): C, 66.23;H, 3.89 ; N, 9.09 :Found; C, 66.21;H, 
3.87;N, 9.06. IR (cm
-1
):1750.00 (CO, Lactone) , 1642.6, (C=N), 1366.70 (CH3). 
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2c Dark brown powder  in 70%, m.p.190
o
C ;anal calc forC18H15NO(293): C,67.51;H,4.17; N,5.08 ;Found:C,67.50; H,4.16; 
N,5.90. IR (cm-1):1728.57(CO, Lactone), 1616.5 (C=N), 1374.40 (CH3). δH:1.246(3H, s, CH3), 3.93(3H, s, OCH3), 
6.89(1H, s, CH-Coumarin), 8.22(1H, s, CH=N-) and 7.88 - 7.49(7H, m, Ar-H). 
2d Brown powder in 70% yield ,m.p.›300
o
C; anal calc forC28H20N2O4(448):C,75.00;H,4.46; 
N,6.25;Found:C,74.98;H,4.44;N,6.21. IR (cm-1):1752.30(CO, Lactone) ,1616.6-1637.1 (C=N) 1364.90 (CH3). δH:6.88-
6.84(2H, s, 2x CH-Coumarins), 7.507(1H, s, N=CH), 7.504 (1H, s, N=CH), 7.49-7.19 (10H, m, Ar-H), 2.49-1.45 (6H, s, 
2xCH3) . 
Synthesis of (2R)-2-(4-methoxyphenyl)-3-(4-methyl-2-oxo-2H-chromen-6-yl)-2,3-
dihydro-1,3-oxazepine-4,7-dione3  
A- Conventional method 
A mixture of 2c (0.01mol; 2.93gm) and anhydrous maleic anhydride (0.01mol) was heated under reflux in dry benzene on 
water bath for 2 hours,  the solid  was collected after concentration and recrystallized from EtOH/petroleum ether. 
B- Microwave method 
A mixture of 2c (0.01mol; 2.93gm) and anhydrous maleic anhydride (0.01mol) was added in Pyrex flask. The mixture was 
irradiated in an ultrasonic cleaner under solvent free for 7 minutes to complete the reaction (Monitored by TCL), cooling to 
room temperature. The reaction mixture was quenched with 20 cm
3
 H2O. The pure product that separate, filtered off and 
recrystallized from EtOH/petroleum ether.  
3 Dark green powder in 60% yield, m .p.244˚C; anal calc for C23H17NO6(403)C, 
68.49;H,4.22;N,3.47;Found:C,68.47;H,4.20;N,3.44. MS(m/z,%)391(5.90%). IR (cm-1): 1750.00(CO, lactone), 
1663.34(C=O). δH:7.498-7.185(7H, m, Ar-H), 6.891(2H, d, CH=CH), 6.268(1H, s, C=CH), 3.916(3H, s, OCH3),6.920(1H, 
s, N-CH-O) , 1.234(3H, s, CH3).  
Synthesis of 4-(4-methoxyphenyl)-9-methyl-7-oxo-2-thioxo-2,7-dihydropyrido[2,3-g] 
quinazoline -6(1H)-carbothioamide 5 
A mixture of 1 (0.01 mol; 1.75gm) and thiourea (0.01 mol; 0.76gm) , 4-methoxybenzaldehyde (0.01 mol; 1.36gm) was 
added and the reaction mixture was heated under microwave irradiation conditions  for 7 minutes in the presence of few 
drops of acetic acid as a catalyst. The solid separate was collected, recrystallized from acetone/ethanol (1:1) to give 5  
5 Gray powder in 90 % yield ,m. p.188ºC;anal calc forC19H17N2O3S(351): C,64.94 ;H,4.88; N,11.96; S,9.12; Found:C,64.90 
;H,4.83 ;N,11.90; S,11.86. IR (cm-1):1595.80 (C=N), 1250.54 (C=S), 2685.39 (SH), 3156.24 (NH), 3265.44, 3368.87 
(NH2). MS (m/z, %)  351(0.62%), 352(0.44%) M
+1
, 353(0.34%) M
+2
, 354(2.17%) M
+3
.  
Synthesis of 4-methyl-6-((5-(4-methyl-2-oxo-2H-chromen-6-yl)-2-thioxo-1,3,5-
trizinan-1-yl)methyl amino)-2H-chromen 2-one 6  
A mixture of 1 (0.02 mol; 3.5gm), thiourea (0.01 mol; 0.57gm) and formaldehyde (0.03mol) in absolute ethanol (50ml) 
was refluxed for 6 hrs. The solid was collected and recrystallized from acetone/ethanol to give 6  
6  Gray powder in 75 % yield, m .p 310 ºC; anal calc for C24H22N4O4S(462): C,62.34 ;H,4.76;N,12.12; S,9.63;Found:  
C,64.32 ;H,4.75 ;N,12.10 ;S,6.90. IR (cm
-1
): 1750.00(CO, lactone), 1203.74(C=S), 2652.33(SH), 3290.39 (NH). δH:9.075( 
t,1H, NHCH2), 9.075(t,1H ,NHCH2N), 9.696 (b,1H, CSNHCH2) , 5.36(dd,2H,CSNHCH2), 5.45(dd,2H ,NHCH2N) , 4.92 
(s,2H,NCH2N) ,1.23-1.45(s,6H,2xCH3-Coumarin),683-7.056(m,6H,Ar-H),6.18. 
Synthesis of8-(4-methoxyphenyl)-1-methyl-9,10,11,12-tetrahydropyrano[3,2-
a]phenan thridin-3-one 7. 
To ethanolic solution of 1(0.01 mol; 1.75 gm) and anisaldehyde (0.01mol) , cyclohexanone  (0.01mol) was added .The 
reaction mixture was heated under reflux for 6 hrs. in the presence of traces of iodine as a catalyst. The solid that 
separate was filtered off and recrystallized from ethanol/water (1:1) to give 7. 
7 Brown powder  in 75% yield, m .p. over 300˚C; anal calc for C24H23NO3(371):C,77.61 ;H,5.70 ;N,3.73; Found:C,77.44; 
H,5.65; N,3.70. IR (cm
-1
):1724.01(CO, lactone), 1606.55 (C=N)
,
 1377.7(CH3). δH: 1.45(s,3H, CH3-Coumarin), 5.45(s,1H-
Comarin), 2.75-3.20(m,8H,4xCH2), 6.85-7.95(m,6H,Ar-H), 3.77(s,3H,OCH3) .MS (m/z %) 371(0.33%).  
Synthesis of ethyl 3-cyano-3-(4,7-dimethyl-2-oxo-4a,10a-dihydro-2H-pyrano[2,3g] 
quinolin -9-yl)propanoate 8 
To a mixture of 1 (0.01 mole; 1.75 gm) and ethyl acetoacetate (0.01mol), ethyl cyano acetate (0.01mol) was added. The reaction 
mixture was fused for 6 hrs .The precipitate was collected and recrystallized from ethanol to give 8. 
8 Brown powder in 60 % yield, m. p.  290 ºC ; anal calc for C20H20N2O4 (352):C,68.18;H,5.68 ;N,7.95; Found: C,68.15; H,5.66; 
N,7.92. IR (cm
-1
):1733.01(CO, lactone), 1365.66(CH3), 2263.03( C N ), 3180(NH).   MS: (m/z %) 336 (4.52%). 
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δH:1.310(3H, t, CH3-ester), 4.29-4.35(2H ,q ,CH2-ester), 2.03(3H,s,CH3-Coumarin), 6.875(1H, s, CH-Coumarin), 
2.699(3H,s, CH3-pyridone), 7.648-7.016(4H, m, Ar-H) and 8.18(1H,NH-pyridine). 
Synthesis of 2-chloro-N-(4-methyl-2-oxo-2H-chromen-6-yl)acetamide 9 
A mixture of 1(0.01 mole; 1.75 gm) and chloroacetylchloride (0.01mol) in (40 ml) methanol was refluxed for 4 hrs. The reaction 
mixture was cooled, poured onto ice, filtered off, dried, and recrystallized from ethanol/water (1:1) to give 9 . 
9 Gray powder  in 60 % yield, m. p. 200 ºC; anal calc for C12H10ClNO3(251.5): C,57.26 ;H, 3.98 ;  N,5.57; Cl,14.12; 
Found:C,57.24; H,3.96; N,5.55; Cl,14.00. IR (cm-1):1628.4 (CO) amide, 1750.0(CO, lactone) , 3297.6(NH).  δH: 9.653(1H, 
s, NH), 6.887(1H, s, CH-Coumarin), 7.492-7.178(3H, m, Ar-H), 3.416(2H, s, COCH2) and 1.3(3H, s, CH3-Coumrin). 
Synthesis of 6-[(2-amino-1,3-oxazol-5-yl)amino]-4-methyl-2H-chromen-2-one 10 or 6-[(2-
amino-1,3-thiazol-5-yl)amino]-4-methyl-2H-chromen-2-one 11. 
 A mixture of 9 (0.01 mole; 2.52 gm) and urea or thiourea (0.01 mol) in (30 ml) ethanol was refluxed for 6 hrs. The reaction mixture 
was cooled, poured onto ice H2O, filtered off, dried, and recrystallized from ethanol to give 10 and 11. 
10 Dark gray powder in 80% yield, m.p.›300
o
C ; anal calc for C13H11N3O3(257): C,60.70;H,4.28;N,16.34 ; 
Found:C,60.68;H,4.25;N,16.31. IR (cm-1): 1720.00(CO, lactone), 1366.77(CH3), 3405.32-3329.18 (NH, NH2), 1591.27 
(C=N) . δH: 1.054(3H, s, CH3), 4.938(2H, s, NH2), 9.696(1H, s, NH), 5.16 (1H, s, CH-Coumarin ring), 5.9 (1H, s, CH-
Oxazole) and 7.561-7491(3H, m, Ar-H). 
11 as dark gray powder  in 70% yield,m.p.›300
o
C ; anal calc for C13H11N3O2S (273):C,57.14 ;H,4.02 ; N,15.38 ; S,11.72; 
Found: C,57.12;H,4.00;N,15.35;S,11.65 . IR (cm-1): 1752.40(CO,lactone) , 1367.00(CH3), 3345.2-3297.4(NHNH2), 1629.2 
(C=N). δH: 1.240(3H, s, CH3), 4.264(2H,s, NH2), 9.671(1H, s, NH), 5.926 (1H, s, CH-Coumarin ring), 6.919 (1H, s, CH-
Thiazole ring) and 7.503-7.185(3H, m, Ar-H). 
Synthesis of N-(4-methyl-2-oxo-2H-chromen-6-yl) acetamide12 
A mixture of 1(0.01mol; 1.75gm) and acetic anhydride (0.01mol) in the presence of glacial acetic acid was refluxed for 2 
hrs. The resulted solution was cooled to room –temp, poured ointo ice/cold water, the solid that separate was filtered off 
and recrystallized from ethanol to give 12. 
12 Gray powder in70 % yield, m .p. 280 ºC ;anal calc for C12H11NO3 (217):C,66.36; H,5.07; N,6.45; 
Found:C,66.34;H,5.00;N,6.44. MS: (m/z %) 217(2.17%). IR (cm
-1
): 1668.0 C=O amid, 1752.0(CO,lactone), 3151.2( NH). 
δH:1.7(3H, s, CH3-Coumarin), 1.905(3H, s, COCH3), 9.707(1H,s, NH), 7.667-6.661(4H,m, Ar-H and CH-Coumarin) . 
Synthesis of (2E)-3-(4-bromophenyl)-N-(4-methyl-2-oxo-2H-chromen-6-yl)prop-2-
enamide 13 
A mixture of 12 (0.01mol; 2.17gm) and 4-bromobenzaldehyde (0.01mol) was reacted under microwave irradiation and 
solvent free conditions for 3 minutes. The solid product was recrystallized from ethanol/petroleum ether (1:1) to give 13. 
13 Brown powder, in 60%  yield, m.p.›300C
0
; anal calc for C19H14BrNO3(384): C,59.38; H,3.65; N,3.65Br,9.11; 
Found:C,59.36; H,3.63; N,3.62; Br,9.00. IR (cm-1)1750.6 (CO, lactone), 1369.50 (CH3), 3287.49 (NH), 1649.69 (C=O) 
amide. δH: 1.977(3H, s, CH3-Coumarin), 8.928(1H,s, NH), 7.788-7.555(7H, m, Ar-H) 5.922(1H, s, CH-Coumarin) ,6.868-
6.840(2H,d,CH=CH). 
Synthesis of6-(5-(4-bromophenyl)-4,5-dihydro-1H-pyrazol-3-ylamino)-4-methyl-2H-
chromen-2-one 14 
 To ethanolic solution of 13 (0.01mol) hydrazine hydrate (0.01 mole) was added .The reaction mixture was heated under 
reflux for 6 hrs. The reaction mixture was cooled to room-temp; Poured onto ice/water, the solid that separate was 
collected, filtered off and recrystallized from ethanol to give 14.  
14 White crystals, in 75% yield ,m.p.185
o
C; anal calc C19H16BrN3O2(397); C,57.30 ;H,4.05;N,10.55;Br,20.06;Found: 
C,57.22;H,4.00;N,10.51;Br,20.00. IR (cm-1) 1750.6(CO, lactone), 1369.50(CH3), 3297.2(NH). δH:1.234(3H, s, CH3-
Coumarin), 8.497(1H,s, NH), 8.520(1H,d,NH–Pyrazoline)),1.801-2.007(2H,dd,CH2-Pyrazoline),3.897(1H,br,1H-Pyrazoline 
) 7.023-7.974(7H, m, Ar-H) 6.950(1H,s, CH-Coumarin) . 
ANTI-INFLAMMATORY SCREENING 
Animals: A total number of 42 adult female Swiss albino rats (140 – 190 g) purchased from the breeding unit of the 
Egyptian Organization for Biological products and Vaccines (Helwan, Egypt) were used in this study. The animals were 
housed in steel mesh cages (3/cage) and maintained on a commercial pellet diet (Egyptian Company of Oils and Soaps) 
for one week before starting the experiment as an acclimatization period. 
Preparation and administration of chemical compounds used  
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Compounds 1, 2a, 11and12 were synthesized, as previously described. A weight of 50 mg was dissolved in 5 ml 10% 
DMSO to prepare stock solutions (10 mg/ml) from these compounds. The solutions were prepared weekly and preserved 
in a well stopper bottle at 4ºc. The synthesized solutions were orally administrated to the animals at a dose level of 
10mg/kg body weight according to [31]. 
Induction of Inflammation 
Induction of inflammation in rats was carried out mainly according to [36]. Inflammation was induced by injecting 0.05 ml of 
1% carrageenan (freshly prepared in saline) subcutaneously into the sub plantar region of the left hind paw. 
Design of the work  
All rats were assorted into 3 reference groups and 4 treated groups according to the following scheme. 
Group 1: Normal control (Con): 
This group comprised 6 normal rats fed a commercial pellet diet and left intact without any treatment. 
Group 2: Carrageenan (Carg): 
This group involved 6 rats injected with 0.05 ml of 1% carrageenan one hour after oral administration of saline 
serving as a reference group for the treated groups. 
Group 3: Vehicle group (Carg +DMSO):  
This group comprised 6 rats received 10% DMSO one hour before carrageenan injection serving as a vehicle 
group.  
Groups 4- 7: 
One hour prior to carageenan injection, the group's 4-7 received a daily oral dose of 10mg/kg body weight of 
compounds 1, 2a, 11 and 12, respectively. 
Anti-inflammatory activity was evaluated by measuring carrageenan induced rat paw edema before (zero time) and after 
carrageenan injection of time intervals 1
st
,2
nd
,3
rd
 and 4
th
hour.Increase in paw thickness was measured as the difference in 
paw thickness at “0 hour” and paw thickness at respective hours. The percentage of inhibition was calculated from the 
formula [37]: 
% Inhibition= [(D0 – Dt) / D0] X 100 
Where D0 = Average paw inflammation of Carg. Group at a given time. 
Dt= Average paw inflammation of treated group at a given time. 
At the end of the treatment period blood samples were taken from the retro-orbital venous plexus under light ether 
anesthesia. Serum was prepared by centrifuging blood samples at 4000 rpm for 5 min. Serum samples were aliquoted 
and stored at -20ºC until analysis, Non hemolyzed sera were analyzed for pro-inflammatory cytokines, IL-6 and TNF-α and 
anti-inflammatory cytokine, IL-10using a commercial assay kit (R & D Systems, USA). 
Statistical analysis: 
The data were presented as mean ± SD. One way analysis of variance (ANOVA) followed by post hoc least significant 
difference analysis (LSD) was performed using the statistical package for social science (SPSS) version 16 to compare all 
the treated groups. The value of p≤ 0.05 was considered statistically significant.  
RESULTS AND DISCUSSION 
Chemistry 
 In this investigation, a series of new pyrazole, oxazole, thiazole, pyridine, pyrimidine and 1,3,oxazepine derivatives  
incoporating coumarin nucleus were designed, synthesized (Schemes 1-5 ), and biologically evaluated for their in vivo 
anti-inflammatory activity[13-17] . Thus, compound 1 condenses easily with aromatic aldehydes namely, cinnamaldehyde, 
3-nitrobenzaldehyd, 4-methoxylbenzaldehyde and terephthalaldehyde in absolute ethanol in the presence of few drops of 
acetic acid under reflux afforded Schiff
'
s bases 2a-d in excellent yield [18]. The chemical structures of 2a-d were 
elucidated on the basis of elemental analysis and spectral data .The 
1
H- NMR spectra indicated the appearance of a 
singlet signal for CH=N function and disappearance of the signal assigned toNH2 group. The structure of 2a also  was 
supported by its mass spectrum, which revealed a molecular ion peak at m/z 289 (0.45% M
+
) corresponding to the 
molecular formula CHON. Condensation of 6-(4-methoxyphenylimino)methyl)-4-methyl-2H-chromen-2-one 2c with 
anhydride namely, (maleic anhydride), under conventional , microwave irradiation and solvent free conditions afforded the 
corresponding cycloaddition product (Z)-2-(4-methoxyphenyl)-3-(4-methyl-2-oxo-2H-chromen-6-yl)-2,3-dihydro-1,3-
oxazepine-4,7-dione 3 based on elemental analysis and spectroscopy (scheme1) [19,20]. 
1
H- NMR spectrum of 3 
exhibited signals at δ 6.891(2H, d, CH=CH), 6.268(1H, s, C=CH), 3.916(3H, s, OCH3) and 6.920(1H, s, N-CH-O) functions 
and disappearance of signal assigned to CH=N function group. The mass spectrum of 3 showed a molecular ion peak at 
m/z 391 (5.90% M
+
). 
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On the other hand, the reactivity of compound 1 was investigated by condensation with (thiourea and 4-
methoxybenzaldehyde) compound 4 under microwave irradiation for seven minutes in the presence of acetic acid afforded 
the corresponding, 7-amino-4-(4-methoxyphenyl)-5-methyl-3,4-dihydrochromeno[2,3-d]pyrimidine-2-thione 5 (scheme 2) 
[21] .  
                  
 
  
 
 
 
 
The IR spectrum of 5 showed absorption bands at 1595.80 
 
C=N, 1250.54 C=S, 2685.39 SH, 3156.24 NH and 3368.87-
3265.44cm
-1
 NH2 and indicated the disappearance of  δ-lactone. Its Mass spectrum showed molecular ion peak at m/z 
351 [M
+
](0.62%). 
The reaction takes place via the following mechanism: 
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Furthermore, compound 1 was condensed with thiourea and formaldehyde in 2:1:3 M ratios in absolute ethanol and few 
drops of acetic acid under reflux to afford the corresponding ,4-methyl-6-(5-(4-methyl-2-oxo-2H-chromen-6-yl)-2-thioxo-
1,3,5-trizinan-1-yl) methylamino )-2H-chromen-2-one 6 [22]. IR spectrum of 6 revealed the absence of NH2 group and 
presence of absorption bands at 1750.0 δ-lactone , 1203.74  C=S, 2652.33  SH and 3290.39cm
-1
 NH.
 
Its 
1
H- NMR 
spectrum indicated the presence of signals at δ 9.075(t,1H,NHCH2N), 9.696(b,1H, CSNHCH2) , 5.36(dd,2H,CSNHCH2), 
5.45(dd,2H,NHCH2N), 4.92(s,2H,CH2) and absence of NH2 protons. 
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The reaction takes place according to the following mechanism: 
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In addition to, compound 1 was easily converted into 8-(4-methoxyphenyl)-1-methyl-9, 10, 11, 12-tetrahydropyrano [3, 2-a] 
phenanthridin-3-one 7 upon treatment with cyclohexanone and anisaldehyde in the presence of iodine as a catalyst under 
reflux for 6 hrs. [23-25] (Scheme 4). The features of this procedure are mild reaction conditions, good to high yields, and 
operational simplicity. IR spectrum of 7 showed absorption bands at 1606.55 cm
-1
 for C=N and the absence of NH2 group. 
Its mass spectrum showed ion peak at m/z , 371 [M
+
] (0.33%) .  
 
O O
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O
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N
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7
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The reaction takes place via mechanism 
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Fusion of 1 with ethyl acetoacetate and ethyl cyanoacetate afforded the corresponding (E)-ethyl 2-cyano-2-(4,7-
dimethyl-2-oxo-2H-pyrano[2,3-g]quinolin-9(6H)-ylidene)acetate 8[26] .IR spectrum of 8 showed absorption bands at 
2263.03, 3180.54 cm
-1
 attributable to C≡N and NH functional groups. The molecular structure of compound 8 also was 
established by 
1
H NMR spectrum which exhibited the presence of triplet at δ 1.310 and a quartet at δ 4.29 assigned for 
ethyl ester moiety and a singlet signal at δ 8.18 for NH-pyridine. The mass spectrum of 8 showed molecular ion peak at 
m/z (336) (4.52%). 
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On the other hand, compound 1 was reacted with chloracetyl chloride in methanol under reflux for 6 hours to afford 2-
chloro-N-(4-methyl-2-oxo-2H-chromen-6-yl)acetamide 9 in which amino group converted into amide group[27]. IR 
spectrum of 9 indicated the absence of amino group and presence of absorption bands at 3297.6 NH and 161628.4 cm
-1
 
CONH Its 
1
H- NMR spectrum showed singlet signals at δ 9.653 NH proton and 3.416 (COCH2) protons. 
The structure of  9 was confirmed chemically upon reaction with urea and/or  thiourea  in boiling ethanol afforded the 
corresponding 6-[(2-amino-1,3-oxazol-4-yl)amino]-4-methyl-2H-chromen-2-one  10  and 6-[(2-amino-1,3-thiazol-4-yl) 
amino]-4-methyl-2H-chromen-2-one 11, respectively[28]. The infrared spectrum in complete agreement with this structure 
that revealed absorption bands at 3405.32-3329.18and 1591.27 cm
-1
 for NH, NH2 and C=N functional groups. The 
1
H-
NMR of compound 10 showed signals at δ 4.938 NH2, 9.696 NH and 5.9 CH-oxazole. IR spectrum of  11 showed 
absorption bands at 3345.2-3297.4and 1629.2 cm
-1
 for NH, NH2 and C=N. Its 
1
H-NMR showed signals at δ 4.264 NH2, 
9.671 NH, and 6.919 CH-thiazole. 
Furthermore, treatment of  1 with acetic anhydride in the presence  of glacial acetic acid afforded the corresponding N-
(4-methyl-2-oxo-2H-chromen-6-yl)-acetamide 12 [29].  Its IR spectrum revealed the presence of absorption bands at 
1668.0, 3151.2 cm
-1
 attributed to C=O, NH and the absence of NH2 group.  The 
1
H-NMR of 12 showed singlet signals at 
δ 1.905 COCH3 and 9.707 NH. Its mass spectrum showed ion peak at m/z (217) (2.17%).Also the structure of 12 was 
further confirmed chemically by its reaction with 4-bromobenzaldehyde for 3 minutes under microwave irradiation and 
solvent free condition to afford (2E)-3-(4-bromophenyl)-N-(4-methyl-2-oxo-2H-chromen-6-yl) prop-2-enamide 13[27]. 
Its
1
H-NMR showed doublet signal at δ 7.788 for olefinic group. 
I S S N  2 3 2 1 - 8 0 7 X 
V o l u m e  1 2  N u m b e r 5 
J o u r n a l  o f  A d v a n c e s  C h e m i s t r y 
 
 l                                                                                        nuoC rof onnIevitav hcraeseR4449 | Page 
May 2016                                                                                                                                          www.cirworl d.com 
Interaction of 13 with hydrazine hydrate in ethanol under reflux afforded hydrazine derivative   14 [28]. Its IR spectrum 
revealed the absence of C=O chalcone absorption band. The 
1
H-NMR of 14 showed signals at δ 2.0-1.8 CH2-pyrazoline, 
4.0, 7.0 for 2NH and 3.9 CH-pyrazoline .  
ANTI-INFLAMMATORY ACTIVITY  
In vivo anti-inflammatory activity was evaluated for the newly synthesized compounds (1, 2a, 11 and 12) using the 
carrageenan-induced rat paw edema protocol. The paw edema volume was evaluated 1, 2, 3and 4hrs after the induction 
of inflammation. The development of edema in the rat paw after injection of carrageenan is biphasic, the initial phase of 
inflammation (0 – 2 hrs) has been attributed to the release of histamine, 5-hydroxytryptamineand kinins, followed by a late 
phase (2.5 – 6hrs) mainly sustained by prostaglandin (PG) release and more recently have been attributed to the induction 
of cyclooxygenase-2 (COX-2) in the tissue [29]. Local neutrophil infiltration and activation also contribute to this 
inflammatory response by producing, among other mediators, oxygen-derived free radicals such as superoxide anion (O2
–
) and hydroxyl radicals [30,31]. 
Data listed in Table 1 and figures 1and 2 indicate that the newly synthesized compounds significantly (p < 0.01) reduce 
the rat paw edema volume during the four hours after administration of the carrageenan, compared to carrageenan group. 
Compounds 1, 2a and 12 exhibited the maximum inhibition of edema after 1 hr from the time of carrageenan 
administration, while compound 11 reached the maximum inhibition of edema after 2hrs and the percentage of inhibition is 
decreased in all the tested compounds after 4hrs from the time of administration. 
Table (1): The paw thickness (mm) in the different studied groups expressed as Mean±SD. 
Groups Zero 1
st
hr 2
nd
hr 3
rd
hr  4
th
hr 
Carg 3.50±0.41 4.36±0.51 4.54±0.46 4.69±0.41 3.94±0.93 
Carg+DMSO 2.84±0.19
a
 3.02±0.11
a 
3.58±0.60
a 
4.19±0.43 3.61±0.86 
1 3.10±0.23
a 
1.94±0.25
a,b
 2.04±0.05
a,b
 2.14±0.11
a,b
 2.28±0.35
a,b 
2a 2.75±0.25
a,c
 1.92±0.11
a,b
 2.42±0.58
a,b
 2.40±0.55
a,b
 2.58±0.54
a,b 
11 3.12±0.23
a,d
 2.76±0.37
a,c,d
 2.24±0.37
a,b
 2.32±0.43
a,b
 2.45±0.21
a,b 
12 3±0.00
a
 1.99±0.29
a,b,e
 2.02±0.08
a,b
 2.35±0.36
a,b
 2.39±0.51
a,b 
a: significance vsCarg group, b: significance vs carg +DMSO group, c: significance vs compound 1, d: significance vs compound 2a, e: 
significance vs compound 11. 
 
Figure (1): Effects of carrageenan and the tested coumarin derivatives on rats through four hours. 
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Figure (2): % Inhibition of inflamed paw of rats treated with the tested coumarin derivatives through four hours. 
These results are in line with [32,33] which reported that coumarin derivatives showed significant inhibition against 
carrageenan induced rat paw edema and inhibit prostaglandin biosynthesis. In addition, 6,7-dimethoxy-4-methylcoumarin 
inhibited PG-E2 production in LPS-stimulated RAW 264.7 cells by reducing the expression of COX-2 [34]. 
Local and/or systemic inflammation is associated with enhanced levels of the pro-inflammatory cytokines TNF-α and IL-
6[35].In the present study, serum levels of the pro-inflammatory cytokines IL-6 and TNF- α were significantly elevated (p < 
0.01) in Carg and Carg +DMSO groups, whereas significant reduction (p < 0.01) was observed in the serum level of IL-10 
as compared to control animals. Administration of the tested compounds, except compound 2a, reduced significantly 
serum IL-6 and induced serum IL-10, compared to Carg group. Moreover, serum TNF- α was significantly reduced in rats 
treated with compound 1. Although serum level of TNF- α was reduced in rats treated with compounds 11 and 12, this 
reduction was statistically non-significant (table 2). These results agree with [36] which illustrated that couramin derivative 
were a potent inhibitor of IL-6 and TNF-α production in LPS-induced RAW 264.7 cells. 
Multiple comparison analysis showed that compounds 11 and 12 were effective in reducing the pro-inflammatory IL-6, 
while compound 1 was effective in reducing the serum level of TNF- α and enhancing the anti-inflammatory IL-10.  
Table (2): Effects of the tested coumarin derivatives and carrageenan treatment on the serum levels of IL-6, TNF-α 
and IL-10 (pg/ml) expressed as Mean ±SD. 
Groups IL-6 TNF-α IL-10 
Con 39.53±2.49 42.33±3.98 111.60±15.46 
Carg 90.27±28.12
a
 76.07±32.09
a
 63.02±23.99
a
 
Carg+DMSO 75.02±33.3
a
 90.20±23.41
a
 83.47±23.82
a
 
1 61.98±25.26
b
 51.53±6.8
b,c
 130.27±25.06
b,c
 
2a 79.47±15.92
a
 92±16.69
a,d
 81.97±19.42
a,d
 
11 53.4±13.4
b,e
 58.3±11.46
c,e
 109.07±6.02
b,c,e
 
12 53.83±19.25
b,e
 61.8±9.05
c,e
 108.80±12.73
b,c,e
 
a: significance vs Con, b: significance vs Carg, c: significance vs Carg +DMSO,d :significance vs compound 1, e: significance vs 
compound 2a. 
CONCLUSION 
In the present study, a series of some new heterocyclic compounds (2-14) incorporating coumarin moiety was synthesized 
and assessed for their anti-inflammatory activity using the carrageenan-induced hind paw edema method.  Some of the 
synthesized compounds exhibited significant anti-inflammatory activity, especially compounds 1, 2a and 12 exhibited the 
maximum inhibition of edema after 1 hr from the time of carrageenan administration, while compound 11 reached the 
maximum inhibition of edema after 2hrs and the percentage of inhibition is decreased in all the tested compounds after 
4hrs from the time of administration. 
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